HALO returns by year
Halozyme Therapeutics Inc. has returned +15.1% annually (CAGR) since 2005. Calendar-year, monthly and weekly total returns for Halozyme Therapeutics Inc. (HALO) below, through August 13, 2026 — the most recent year is year-to-date.
Halozyme Therapeutics Inc. returns by year (2005–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $67.30 | $100.64 | +0.0% | +49.5% | |
| 2025 | $47.81 | $67.30 | +0.0% | +40.8% | |
| 2024 | $36.96 | $47.81 | +0.0% | +29.4% | |
| 2023 | $56.90 | $36.96 | +0.0% | -35.0% | |
| 2022 | $40.21 | $56.90 | +0.0% | +41.5% | |
| 2021 | $42.71 | $40.21 | +0.0% | -5.9% | |
| 2020 | $17.73 | $42.71 | +0.0% | +140.9% | |
| 2019 | $14.63 | $17.73 | +0.0% | +21.2% | |
| 2018 | $20.26 | $14.63 | +0.0% | -27.8% | |
| 2017 | $9.88 | $20.26 | +0.0% | +105.1% | |
| 2016 | $17.33 | $9.88 | +0.0% | -43.0% | |
| 2015 | $9.65 | $17.33 | +0.0% | +79.6% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from HALO's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is Halozyme Therapeutics Inc.'s average annual return?
- Since 2005, Halozyme Therapeutics Inc. (HALO) has returned about 15.1% a year (the compound annual growth rate) and an average calendar-year return of 36.0%.
- What were Halozyme Therapeutics Inc.'s best and worst years?
- Over 2005–2026, the best year was 2006 (+342.3%) and the worst was 2016 (-43.0%).
- How often is Halozyme Therapeutics Inc. up in a year?
- 12 of the 21 full years since 2005 were positive — about 57% of the time.